Site Search
410 result(s) found for “ adaptive therapy”
-
Turnstone Biologics and Moffitt Cancer Center Announce Strategic Alliance to Advance Next-Generation TIL Therapies for Solid Tumors
Strategic alliance significantly expands ongoing multi-year collaboration by granting Turnstone broader access and enhanced benefits at Moffitt
-
Moffitt Researchers Identify Key Mechanisms of Action Differences in 2 Immune Checkpoint Inhibitor Combination Therapies for Advanced Melanoma
Anti-PD1/CTLA-4 and anti-PD1/LAG-3 therapies have different requirements for CD4 T Cells
-
Small Cell Lung Cancer Patients Who Have Failed Previous Therapies Now Have New Hope — the First in 20 Years
New drug allows your T cells to go to work, destroying cancer.
-
Small Cell Lung Cancer Patients Who Have Failed Previous Therapies Now Have New Hope — the First in 20 Years
Small Cell Lung Cancer Patients Who Have Failed Previous Therapies Now TAMPA, Fla. — The Food and Drug Administration announced the expanded approval...
-
A New Course in Prostate Cancer Care
An adaptive therapy trial at Moffitt offers a way to manage prostate cancer while preserving quality of life
-
Moffitt Highlighted in London Museum Exhibit
Cancer center is one of the only U.S. institutions included in the history of cancer showing
-
Moffitt Cancer Center Uses AI to Develop More Personalized Cancer Treatment Strategies
Innovative study harnesses deep reinforcement learning to tailor adaptive treatment schedules for metastatic prostate cancer, doubling time to...
-
Working to Treat a Deadly Form of Prostate Cancer
A deadly form of prostate cancer is more common that experts previously thought. Now, Moffitt is working to combat it.
-
Next Generation Research Highlighted at Moffitt Scientific Symposium
Oncology trainees feature more than 200 presentations
-
Moffitt Cancer Center Showcases Top Science
Researchers from around the globe share the latest at American Association for Cancer Research Annual Meeting